Insulet Corp (PODD)
174.43
+1.01
(+0.58%)
USD |
NASDAQ |
May 03, 16:00
174.46
+0.03
(+0.02%)
After-Hours: 20:00
Insulet Cash from Operations (Quarterly): 45.20M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 45.20M |
September 30, 2023 | 56.00M |
June 30, 2023 | 44.00M |
March 31, 2023 | 0.50M |
December 31, 2022 | 50.70M |
September 30, 2022 | 56.70M |
June 30, 2022 | 25.30M |
March 31, 2022 | -13.70M |
December 31, 2021 | -25.50M |
September 30, 2021 | -25.80M |
June 30, 2021 | 18.30M |
March 31, 2021 | -35.10M |
December 31, 2020 | 17.00M |
September 30, 2020 | 44.20M |
June 30, 2020 | 26.40M |
March 31, 2020 | -3.60M |
December 31, 2019 | 46.90M |
September 30, 2019 | 31.10M |
June 30, 2019 | 13.90M |
March 31, 2019 | 6.50M |
December 31, 2018 | 30.44M |
September 30, 2018 | 15.86M |
June 30, 2018 | -6.129M |
March 31, 2018 | -4.266M |
December 31, 2017 | 21.89M |
Date | Value |
---|---|
September 30, 2017 | 23.28M |
June 30, 2017 | 17.96M |
March 31, 2017 | -21.84M |
December 31, 2016 | 20.07M |
September 30, 2016 | 2.677M |
June 30, 2016 | 3.681M |
March 31, 2016 | -10.52M |
December 31, 2015 | -18.60M |
September 30, 2015 | 8.746M |
June 30, 2015 | 0.785M |
March 31, 2015 | -3.488M |
December 31, 2014 | 4.607M |
September 30, 2014 | 4.822M |
June 30, 2014 | 0.508M |
March 31, 2014 | -1.017M |
December 31, 2013 | -3.518M |
September 30, 2013 | 3.694M |
June 30, 2013 | 4.372M |
March 31, 2013 | -1.20M |
December 31, 2012 | -5.593M |
September 30, 2012 | -3.449M |
June 30, 2012 | -11.11M |
March 31, 2012 | -8.903M |
December 31, 2011 | -7.668M |
September 30, 2011 | -0.836M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-35.10M
Minimum
Mar 2021
56.70M
Maximum
Sep 2022
19.61M
Average
25.30M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
Abbott Laboratories | 3.038B |
Stryker Corp | 204.00M |
Tandem Diabetes Care Inc | -7.216M |
Becton Dickinson & Co | 515.00M |
ResMed Inc | 402.03M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -31.60M |
Cash from Financing (Quarterly) | 2.20M |
Free Cash Flow | 36.50M |
Free Cash Flow Per Share (Quarterly) | 0.1615 |
Free Cash Flow to Equity (Quarterly) | 18.20M |
Free Cash Flow to Firm (Quarterly) | 14.08M |
Free Cash Flow Yield | 0.28% |